Management Team

James Clubb

MSc, Project Manager

James Clubb has expertise in the development of cell and gene therapies and preclinical research tools.  James is currently completing his PhD as Marie Skłodowska-Curie fellow, during which he evaluated TILT-123 as a potential new treatment option for head and neck cancer using novel preclinical models. James is now responsible for the development and management of TILTs’ clinical trial sample analyses.

Akseli Hemminki

MD, PhD, eMBA, Founder & CEO and Member of the Board of Directors

Aino Kalervo

MSc, MS, Chief Business Officer

Kari Varkila

MD, PhD, MBA, Chief Medical Officer

Tuija Keinonen

PhD, Chief Regulatory Officer, Chair of the Board of Directors

Suvi Sorsa

PhD, VP of Clinical Affairs

Víctor Cervera-Carrascón

PhD, VP of Business Development

Elina Haavisto

MSc, Head of CMC Regulatory Affairs

Claudia Kistler

PhD, Head of Clinical Operations

Riikka Havunen

PhD, Head of R&D

João Manuel Santos

PhD, Head of Immunology

Cristina Pereira

PhD, Head of Manufacturing

Veera Kukkurainen

MSc, Laboratory Project Manager

Henrik Roosvall

Business Operations Manager

Remi Gloeckler

PhD, CMC Advisor